Structure and functionality in flavivirus NS-proteins: perspectives for drug design.
Flaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA genome. Besides yellow fever virus, a landmark case in the history of virology, members of the Flavivirus genus, such as West Nile virus and dengue virus, are increasingly gaining attention due to their re-emergenc...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
_version_ | 1826265806452817920 |
---|---|
author | Bollati, M Alvarez, K Assenberg, R Baronti, C Canard, B Cook, S Coutard, B Decroly, E de Lamballerie, X Gould, E Grard, G Grimes, J Hilgenfeld, R Jansson, A Malet, H Mancini, E Mastrangelo, E Mattevi, A Milani, M Moureau, G Neyts, J Owens, R Ren, J Selisko, B Speroni, S |
author_facet | Bollati, M Alvarez, K Assenberg, R Baronti, C Canard, B Cook, S Coutard, B Decroly, E de Lamballerie, X Gould, E Grard, G Grimes, J Hilgenfeld, R Jansson, A Malet, H Mancini, E Mastrangelo, E Mattevi, A Milani, M Moureau, G Neyts, J Owens, R Ren, J Selisko, B Speroni, S |
author_sort | Bollati, M |
collection | OXFORD |
description | Flaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA genome. Besides yellow fever virus, a landmark case in the history of virology, members of the Flavivirus genus, such as West Nile virus and dengue virus, are increasingly gaining attention due to their re-emergence and incidence in different areas of the world. Additional environmental and demographic considerations suggest that novel or known flaviviruses will continue to emerge in the future. Nevertheless, up to few years ago flaviviruses were considered low interest candidates for drug design. At the start of the European Union VIZIER Project, in 2004, just two crystal structures of protein domains from the flaviviral replication machinery were known. Such pioneering studies, however, indicated the flaviviral replication complex as a promising target for the development of antiviral compounds. Here we review structural and functional aspects emerging from the characterization of two main components (NS3 and NS5 proteins) of the flavivirus replication complex. Most of the reviewed results were achieved within the European Union VIZIER Project, and cover topics that span from viral genomics to structural biology and inhibition mechanisms. The ultimate aim of the reported approaches is to shed light on the design and development of antiviral drug leads. |
first_indexed | 2024-03-06T20:29:24Z |
format | Journal article |
id | oxford-uuid:308c41c0-418e-4a58-83c7-0289852cae77 |
institution | University of Oxford |
language | English |
last_indexed | 2024-03-06T20:29:24Z |
publishDate | 2010 |
record_format | dspace |
spelling | oxford-uuid:308c41c0-418e-4a58-83c7-0289852cae772022-03-26T13:02:10ZStructure and functionality in flavivirus NS-proteins: perspectives for drug design.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:308c41c0-418e-4a58-83c7-0289852cae77EnglishSymplectic Elements at Oxford2010Bollati, MAlvarez, KAssenberg, RBaronti, CCanard, BCook, SCoutard, BDecroly, Ede Lamballerie, XGould, EGrard, GGrimes, JHilgenfeld, RJansson, AMalet, HMancini, EMastrangelo, EMattevi, AMilani, MMoureau, GNeyts, JOwens, RRen, JSelisko, BSperoni, SFlaviviridae are small enveloped viruses hosting a positive-sense single-stranded RNA genome. Besides yellow fever virus, a landmark case in the history of virology, members of the Flavivirus genus, such as West Nile virus and dengue virus, are increasingly gaining attention due to their re-emergence and incidence in different areas of the world. Additional environmental and demographic considerations suggest that novel or known flaviviruses will continue to emerge in the future. Nevertheless, up to few years ago flaviviruses were considered low interest candidates for drug design. At the start of the European Union VIZIER Project, in 2004, just two crystal structures of protein domains from the flaviviral replication machinery were known. Such pioneering studies, however, indicated the flaviviral replication complex as a promising target for the development of antiviral compounds. Here we review structural and functional aspects emerging from the characterization of two main components (NS3 and NS5 proteins) of the flavivirus replication complex. Most of the reviewed results were achieved within the European Union VIZIER Project, and cover topics that span from viral genomics to structural biology and inhibition mechanisms. The ultimate aim of the reported approaches is to shed light on the design and development of antiviral drug leads. |
spellingShingle | Bollati, M Alvarez, K Assenberg, R Baronti, C Canard, B Cook, S Coutard, B Decroly, E de Lamballerie, X Gould, E Grard, G Grimes, J Hilgenfeld, R Jansson, A Malet, H Mancini, E Mastrangelo, E Mattevi, A Milani, M Moureau, G Neyts, J Owens, R Ren, J Selisko, B Speroni, S Structure and functionality in flavivirus NS-proteins: perspectives for drug design. |
title | Structure and functionality in flavivirus NS-proteins: perspectives for drug design. |
title_full | Structure and functionality in flavivirus NS-proteins: perspectives for drug design. |
title_fullStr | Structure and functionality in flavivirus NS-proteins: perspectives for drug design. |
title_full_unstemmed | Structure and functionality in flavivirus NS-proteins: perspectives for drug design. |
title_short | Structure and functionality in flavivirus NS-proteins: perspectives for drug design. |
title_sort | structure and functionality in flavivirus ns proteins perspectives for drug design |
work_keys_str_mv | AT bollatim structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT alvarezk structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT assenbergr structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT barontic structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT canardb structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT cooks structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT coutardb structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT decrolye structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT delamballeriex structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT goulde structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT grardg structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT grimesj structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT hilgenfeldr structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT janssona structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT maleth structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT mancinie structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT mastrangeloe structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT mattevia structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT milanim structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT moureaug structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT neytsj structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT owensr structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT renj structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT seliskob structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign AT speronis structureandfunctionalityinflavivirusnsproteinsperspectivesfordrugdesign |